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Summary 
In genetically susceptible strains of mice, such as A/J and (C57BL/6J  ￿  A/J)F 1 hybrids, neona- 
tal thymectomy-induced autoimmune ovarian dysgenesis (AOD) is characterized by the devel- 
opment of antiovarian autoantibodies,  oophoritis,  and atrophy.  Temporally, atrophy may be 
observed during and after the regression of inflammatory infiltrates from the ovary. Histologi- 
cally, lesions appear as areas devoid of ovarian follicles in all stages of development that have 
been replaced by luteinized interstitial  cells.  We report here the mapping of Aod2,  the locus 
that controls this phenotype, to mouse chromosome 3 within a region encoding//2 and Fgfb. 
Most significant, however, is the co-localization of Aod2 to Idd3, a susceptibility gene that plays 
a  role  in  autoimmune  insulin-dependent  type  1  diabetes  mellitus  in  the  nonobese  diabetic 
mouse. 
p remature  ovarian  failure  (POF) 1 has  been  recognized 
for some time as a  cause  of infertility in women, but 
the precise etiology of the disease remains ill defined. Both 
autoimmune  and  genetic  components  have  been  impli- 
cated in the disease  process (1-6). With regard to autoim- 
munity,  women  with  POF  frequently  present  with  anti- 
ovarian autoantibodies, ovarian lymphocytic infiltrates, and 
abnormalities in T  cell subsets and lymphokine levels (1, 2). 
In addition, POF is observed in association with other or- 
gan-specific autoimmune disorders, such as type 1 and type 
2  polyendocrinopathies,  and  immunosuppressive  therapy 
has been successful at restoring normal ovarian function (1). 
A  genetic  component  in  the  etiology of POF  has  also 
been  demonstrated  in  normal  46XX  karyotype  families 
(3-6). The familial nature of POF was documented across 
multiple generations in a number of kindreds and is consis- 
tent  with  an  autosomal-dominant,  sex-limited  vertical 
transmission  (5,  6).  In fact, it has been suggested that this 
form of POF may not be as rare as believed because of pre- 
vious failures to establish detailed menopausal histories  on 
both sides of a patient's family (6). 
A  highly  useful  system for  studying both  the  autoim- 
nmne  and genetic  components of POF  is the  day 3  thy- 
mectomy (D3Tx)-induced model of autoimmune ovarian 
dysgenesis  (AOD)  in  mice  (7-10).  The  D3Tx  model  of 
AOD  is  unique  in  that  disease  induction  depends  exclu- 
sively on perturbation  of the  normal developing immune 
system, is T  cell mediated, and is strain specific. For exam- 
ple, D3Tx A/J and (C57BL/6J  ￿  A/J)F1  hybrid mice are 
susceptible to AOD, whereas C57BL/6J mice are resistant 
(11).  AOD is phenotypically characterized by the presence 
of antiovarian  autoantibodies,  ovarian  lymphocytic  infil- 
trates (oophoritis), and ovarian atrophy (7-10).  Oophoritis 
is first observed in the ovaries of D3Tx mice at 3-4 wk af- 
ter thymectomy and is presented as infiltration of the hilar 
region,  which later extends into the interfollicular areas as 
well  as  within  growing  and  antral  follicles  (7).  Subse- 
quently,  the infiltrating cells may regress from the ovaries, 
which then become atrophic. Atrophic areas are devoid of 
ovarian  follicles  in  all  stages  of development  and  are  re- 
placed by interstitial cells that appear luteinized. 
Previously, we  demonstrated that Aodl,  the  gene  con- 
trolling the development of both the antiovarian autoanti- 
body  and  T  cell-mediated  autoimmune  responses  after 
D3Tx, maps to chromosome 16 within a region encoding 
several  loci  of immunologic  relevance  (11).  In  contrast, 
however, the phenotypic expression of ovarian atrophy was 
not linked to Aodl.  In this study, we report the identifica- 
tion and mapping of the gene controlling the phenotypic 
expression of atrophy to chromosome 3. 
~Abbreviations used in this paper: AOD, autoimmune ovarian dysgenesis; 
D3Tx, day 3 thymectomy; IDDM, insulin-dependent diabetes mellitus; 
POF, premature  ovarian failure. 
Materials  and Methods 
Animals.  Female  (C57BL/6J  ￿  A/J)F  1  hybrid  and  male 
C57BL/6J  mice were purchased  from The Jackson  Laboratory 
631  J. Exp. Med. ￿9  The Rockefeller University Press ￿9 0022-1007/96/02/631/07  $2.00 
Volume 183  February 1996 631-637 (Bar Harbor, ME). (C57BL/6J  X A/J)F  1 X C57BL/6J back-cross 
(BC1)  mice were  generated and D3Tx performed  under ether 
anesthesia using a suction pipette technique (11). At 24 d of age, 
the  animals  were  weaned and separated  by sex. Animals were 
maintained on mouse pellets  (Ralston-Purina, St.  Louis,  MO) 
and acidified water ad libitum. D3Tx females were killed at 60 d 
of age. Individual serum samples were obtained, the ovaries were 
collected for histopathologic  analysis, and livers were snap frozen 
for the isolation of DNA (11, 12). 
Histopathologic  Analysis ofOvarian Atrophy.  The  ovaries  of the 
D3Tx BC1  mice were fixed in Bouin's fixative and embedded in 
paraffin, and 5-~m sections  were stained with hematoxylin and 
eosin.  Multiple-step sections  were  evaluated in a  double-blind 
fashion and scored  for oophoritis and atrophy as previously de- 
scribed (1 l). 
DNA Isolation.  Genomic DNA was isolated from liver tissue as 
previously described  (11, 12). Briefly, 0.5 g of tissue, maintained 
in liquid nitrogen, was pulverized with a mortar and pestle. The 
cells were lysed and deproteinized with SDS and proteinase K, 
followed  by  phenol/chloroform/isoamyl alcohol  extraction(s). 
The DNA was then precipitated in sodium acetate with isoamyl 
alcohol,  suspended  in TE  (10  mM  Tris-HC1,  pH  7.4,  1 mM 
EDTA), reprecipitated  with ammonium acetate and ethanol, and 
resuspended in TE. Working aliquots of all DNA samples were pre- 
pared by bringing them to the appropriate  concentrations in TE' 
(10 mM Tfis-HC1, pH 7.4, 0.1 mM EDTA) and then stored at 4*C. 
Microsatellite Primers, Amplification Conditions, and Detection of 
PCR Products.  Microsatellite  primers were purchased  from Re- 
search Genetics Incorporated (Huntsville,  AL) or synthesized ac- 
cording to sequences obtained through the Whitehead Institute/ 
MIT Mouse Genome Database (13). PCIL parameters  for micro- 
satellite typing were performed as previously described  (11-13). 
MicrosateUite alleles were resolved  by electrophoresis  on large- 
format denaturing polyacrylamide  gels and visualized by autorad- 
iography on film (Eastman Kodak Co., Rochester, NY). 
Linkage Analysis.  74 of the 144 animals studied exhibited au- 
toimmune oophoritis (11). Of the 74 with oophoritis,  25 devel- 
oped  atrophy.  This  population was  used  for  linkage  analysis. 
Linkage  of marker loci to atrophy was evaluated  by X  2 analysis 
against a predicted frequency of 1:1 for marker loci, with linkage 
significant at P ~<0.001. Segregation  distortion was examined by 
detemfining the genotype frequency of randorrdy selected marker 
loci distributed throughout the genome in the  144 D3Tx BC1 
mice. In no case was significant distortion from the predicted fre- 
quency of 1:1 observed. The maximum likelihood positional esti- 
mate for the location of the Aod2 locus  on chromosome 3 was 
performed using the MAPMAKER program (14). Genome cov- 
erage was estimated  by using the position of marker loci as re- 
ported on the Whitehead Institute/MIT Mouse Genome Data- 
base and applying a value of 20 cM on each side of the marker loci. 
Results  and Discussion 
In mice with autoimmune oophoritis, the infiltrating cells 
may regress from the ovaries, which then become atrophic. 
Of the 74 D3Tx BC1  mice with oophoritis, 25  exhibited 
this  phenotype  (Fig.  1).  To  map  the  gene  or  genes  that 
control atrophy, a linkage map was generated using the af- 
fected  population and  a  panel of 131  microsatellites that 
distinguish C57BL/6J and A/J mice. This analysis revealed 
significant linkage of atrophy to  marker loci on chromo- 
some 3  (Table 1).  Maximal linkage was seen on chromo- 
some  3  to  D3Mit224,  D3Mit63,  D3Mit133,  D3Mit226, 
D3Mit182,  D3Mit227,  D3Mit64,  D3Mit5,  D3Mit6,  and 
D3Mit65 (all with X  2 =  11.6, P  =  0.0007). We have desig- 
nated this  gene Aod2.  Maximum likelihood estimates for 
the location of Aod2 on chromosome 3 were carried out by 
multilocus linkage  analysis  (14).  The  results  place  Aod2 
within a  95%  confidence interval bordered  by D3Mit21 
(112) (LOD  =  2.09)  and D3Mit154  (LOD  =  2.09)  at  16 
and 25 cM from the centromere of chromosome 3, respec- 
tively. 
Figure 1.  Progression  from oophoritis to ovarian  atrophy in D3Tx mice. (A) A normal ovary containing  growing and antral follicles; (B) an atrophic 
ovary containing  a large cluster of infiltrating  lymphocytes  (arrows); (C) an atrophic ovary  with minimal  inflammatory  cells. 
632  Genetic Control of Autoimmune Ovarian Dysgenesis Table 1.  Linkage Map of the Mouse Genome with Linkage of 
Marker Loci to Atrophy as a Function  of Oophoritis* 
Chromosome (cM) 2.  Locus 
Atrophy 
Ho  He  X  2 ~43~  P value 
1 (8)  DIMit3  13  11 
1 (18)  DIMit170  10  14 
1 (45)  DIMit46  13  11 
1 (67)  D1Nds2  11  13 
1 (87)  D1Mit15  16  8 
1 (94)  Crp  14  10 
1 (110)  D1Mit17  16  8 
1 (113)  DIMit210  12  9 
2 (8)  D2Mit5  11  13 
2  (19)  D2Mit82  12  13 
2 (29)  D2Mit7  12  12 
2 (51)  D2Mit14  11  13 
2  (52)  D2Mit43  13  12 
2 (79)  D2Mit143  11  14 
2  (82)  D2Mit51  12  12 
2 (100)  D2Mit266  11  14 
3  (5)  D3Mit62  6  18 
3 (13)  D3Mit55  7  18 
3 (16)  D3Mit21  5  20 
3 (17)  D3Mit94  6  19 
3 (17)  D3Mit224  4  21 
3 (17)  D3Mit63  4  21 
3  (17)  D3Mit133  4  21 
3  (17)  D3Mit226  4  21 
3 (18)  D3Mit182  4  21 
3 (18)  D3Mit227  4  21 
3 (18)  D3Mit64  4  21 
3 (18)  D3Mit5  4  21 
3 (19)  D3Mit6  4  21 
3 (20)  D3Mit65  4  21 
3  (23)  D3Mit185  5  20 
3  (23)  D3Mit173  5  19 
3 (23)  D3Mit7  5  20 
3  (23)  D3Mit171  5  20 
3 (23)  D3Mit228  6  19 
3 (23)  D3Mit 170  5  20 
3  (25)  D3Mit154  5  20 
3 (27)  D3Mit22  6  19 
3  (31)  D3Mit40  7  17 
3  (46)  D3Mit14  10  15 
3 (51)  D3Mit38  9  13 
3  (60)  D3Mit44  11  12 
3  (62)  D3Mit32  10  12 
6.0  0.014 
4.8  0.028 
9.0  0.003 
6.8  0.009 
11.6  0.0007 
11.6  0.0007 
11.6  0.0007 
11.6  0.0007 
11.6  0.0007 
11.6  0.0007 
11.6  0.0007 
11.6  0.0007 
11.6  0.0007 
11.6  0.0007 
9.0  0.003 
8.2  0.004 
9.0  0.003 
9.0  0.003 
6.8  0.009 
9.0  0.003 
9.0  0.003 
6.8  0.009 
4.2  0.041 
Table  1.  Continued 
Chromosome (cM) 2:~  Locus 
Atrophy 
Ho  He  X  2 ~43~  P value 
4  (9) 
4  (34) 
4  (34) 
4 (51) 
4  (68) 
5 (16) 
5 (18) 
5 (27) 
5 (46) 
5 (47) 
5 (53) 
5 (64) 
5 (76) 
6 (21) 
6 (13) 
6 (26) 
6 (40) 
6 (54) 
6 (64) 
7 (9) 
7 (19) 
7 (30) 
7 (55) 
8  (13) 
8 (36) 
8  (55) 
8  (69) 
8 (74) 
9 (14) 
9 (35) 
9 (41) 
9  (44) 
9 (52) 
9 (57) 
9 (67) 
10 (3) 
10 (10) 
10 (13) 
10 (41) 
10 (50) 
10 (67) 
D4Mit2  13  10 
D4Mit166  14  11 
D4Mit15  14  9 
D4Mit16  14  10 
D4Mit14  12  11 
D5Mit13  14  11 
D5Mitl I  12  13 
D5Mit197  13  12 
D5Nds3  12  12 
D5Mit24  11  13 
D5Mit188  10  12 
D5Mit30  14  8 
D5Mit99  13  12 
D6Mit74  14  9 
D6Mit183  14  11 
D6Mit8  13  11 
D6Mit36  12  12 
D6Mit59  14  10 
D6Mit15  13  11 
D7Mit77  12  11 
D7Mit27  12  12 
D7Ndsl  13  10 
D7Mit71  15  9 
D8Mit4  13  11 
D8Mit31  11  12 
D8Mit112  15  10 
D8Mit14  11  13 
D8Mit156  11  14 
D9Mit2  14  10 
D9Mit 105  13  9 
D9Mit73  15  10 
D9Mitl I  16  8 
D9Mit 12  13  9 
D9Mit51  14  11 
D9Mit18  14  10 
DlONdsl  11  13 
DlOMit2  14  10 
DlOMitl06  14  11 
D10Mit42  14  11 
DIOMitlO  14  11 
D10Mit14  14  10 
Continued  Continued 
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Chromosome (cM)  2~:  Locus 
Atrophy 
Ho  He  X  2->43~  Pvalue  Chromosome (cM)  2~:  Locus 
Atrophy 
Ho  He  X  ~ -->4  3~  P value 
11  (5)  D1 tMit2 
11  (26)  D11Mit86 
11  (37)  D11Mit4 
11  (49)  D 11Mit4 I 
12 (4)  D12Mitl 
12 (7)  D12MitI2 
12 (34)  D12Mit5 
12 (60)  D12NdslO 
13 (9)  D13Mit3 
13 (28)  D13Mit21 
13 (46)  D13Mit45 
14 (11)  D14Mit14 
14 (31)  D14Mit37 
14 (49)  D14Mit7 
14 (67)  D14Mit36 
15 (6)  D15Mit11 
15 (8)  D15Mit53 
15 (18)  D15Mit5 
15 (34)  D 15Mit28 
15 (61)  D15Mit16 
16 (0)  D16Mit32 
16 (8)  D16Mit87 
16 (16)  D16Mit29 
16 (24)  D 16MIT57 
16 (26)  D16MIT58 
16 (27)  Dt6Mit4 
16 (27)  D 16Mit59 
16 (35)  D16Mit5 
16 (43)  D16Mit19 
17 (10)  D17Nds3 
17 (20)  D17Mit10 
17 (31)  DI 7Mit20 
17 (45)  D 17Mit2 
18 (5)  Dl8Mit20 
18 (17)  D18Mit24 
18 (27)  D18Mit9 
18 (38)  DISMit4 
19 (17)  D19Mit16 
19(28)  D19Mit19 
19(46)  D19Mit1 
12  12 
2  8 
12  13 
10  14 
13  11 
12  12 
11  13 
10  14 
14  10 
9  14 
9  15 
10  13 
13  11 
13  11 
14  10 
14  10 
10  14 
8  16 
12  12 
14  10 
7  18 
9  15 
8  17 
8  17 
8  17 
7  18 
7  18 
8  17 
12  13 
10  14 
11  13 
11  10 
14  9 
11  12 
12  12 
11  13 
11  13 
14  10 
16  8 
14  10 
4.8  0.028 
4.8  0.028 
4.8  0.028 
Continued 
X  (0)  DXMit55  12  12 
X  (27)  DXMit22  12  13 
X  (32)  DXMit25  11  t 3 
X  (32)  DXMitl  1l  13 
X  (39)  DXMitI6  10  14 
X  (42)  DXNds3  10  15 
X  (57)  DXMit36  9  16 
*The  atrophic phenotype  was determined  histologically using the 25 
animals exhibiting the most severe oophoritis. 
*Markers are arranged centromeric  to telomeric.  Locations are as re- 
ported on the Whitehead Institute/MIT Mouse Genome Database. All 
are PCR-based microsatellites that distinguish C57BL/6J and A/J. 
-~  Genotype frequency differences for atrophy were tested within the af- 
fected population by X  2 against a predicted frequency of 1  : 1 for marker 
loci. Only X  2 ->4 are shown. 
He, heterozygous; Ha, homozygous. 
No  other  regions  of the  genome  exhibited  significant 
linkage to atrophy, suggesting that Aod2 is the major gene 
controlling the development of this phenotype. This inter- 
pretation is consistent with  the fact that we have  covered 
~94%  of the  total genome  with  an  average marker locus 
density of 11.4 cM in our linkage analysis (Table 2).  How- 
ever,  our results  do  not  exclude  the  possible existence of 
one  or more minor loci that we have  not detected in this 
analysis but that might be identified using larger numbers of 
affected BC1  progeny and  additional marker loci.  In fact, 
the four animals exhibiting atrophy that were homozygous 
for all markers across the support interval are suggestive of 
the existence of such genes. 
These mapping data place Aod2 within a 95% confidence 
interval encoding two genes of particular immunologic rel- 
evance. The first is II2,  and the second is fibroblast growth 
factor basic  (Fgfo)  (15).  The  function  of I12 in cell-medi- 
ated autoimmune reactions is well documented (16). How- 
ever,  the  role  of Fgfb  in  T  cell-mediated inflammatory 
responses such as oophoritis has only recently been  elabo- 
rated.  Blomick  et  al.  (17)  demonstrated  that  both  CD4 + 
and CD8 § T  cells synthesize and export Fgfb. With regard 
to  ovarian  function,  Fgtb  is  mitogenic  for  granulosa  (18) 
and luteal ceils (19) and modulates steroidogenesis in gran- 
ulosa  cells  (20-24),  theca-interstitial cells  (25),  and  luteal 
tissues  (26).  Fgfb is also present in the  corpora lutea  (27), 
luteal cells (28),  and granulosa cells (29).  In addition, spe- 
cific high-affinity binding sites for Fgib have  been  identi- 
fied on  granulosa  cells (30,  31)  and  luteal cells (28).  Such 
observations  suggest  that  Fgfb  may  have  an  autocrine  or 
paracrine effect on the regulation of cell growth and differ- 
entiated functions  of ovarian cells (32).  It is therefore not 
634  Genetic Control of Autoimmune Ovarian Dysgenesis Table 2.  Percentage  of  Mouse Genome Covered by Exclusion 
Mapping* 
Percentage of 
chromosome  Largest 
Chromosome  covered  gap (cM) 
1  92  27 
2  91  27 
3  100  15 
4  94  25 
5  100  19 
6  100  14 
7  93  25 
8  96  23 
9  99  23 
10  90  28 
1l  77  39 
12  80  27 
13  97  22 
14  100  20 
15  89  27 
16  100  15 
17  100  14 
18  100  12 
19  100  19 
X  91  27 
Total  94 
*Coverage of the  genome  was  estimated by  using the  position of 
marker loci as reported on the Whitehead Institute/MIT  Mouse Ge- 
nome Database and applying a value of 20 cM on each side of the 
marker loci. 
inconceivable that Fgfl0 plays a role in the development and 
progression of ovarian atrophy. 
Most important, however, is the co-localization of Aod2 
with  Idd3,  one  of the  susceptibility  loci  controlling auto- 
immune insulin-dependent  type  1 diabetes mellitus  (IDDM) 
in the nonobese diabetic mouse  (33).  However, it is worth 
noting that the maximum support interval (from D3Mit224; 
LOD =  2.75 to D3Mit65; LOD =  2.75) for Aod2 is slightly 
telomeric  of both  112  and  Fg/b.  This  result  suggests  that 
AOD and IDDM may share a common susceptibility gene. 
If,  indeed,  it  is  verified  under  further  analysis,  that Aod2 
and Idd3 are identical, then the following conclusion is ev- 
ident.  Non-MHC-linked  disease  susceptibility  genes  can 
be divided into two distinct classes:  those that play a role in 
multiple  autoimmune  diseases  and  those  that  are  disease 
specific.  MHC-linked  immune  response  genes  clearly es- 
tablish a precedent for the former. Similarly, co-localization 
of susceptibility  loci  in  autoimmune  orchitis  and  IDDM 
has been reported (34). 
The  fact  that  ovarian  atrophy  is  a  genetically  distinct 
component of AOD is of potential significance endocrino- 
logically. In D3Tx mice, alterations in the plasma levels of 
gonadotropin hormones are observed before the  develop- 
ment of autoimmunity  (35),  and similar results are seen in 
prenatally thymectomized nonhuman primates  (36).  It has 
been suggested that,  in addition  to ovarian autoimmunity, 
endocrinologic aberrations  may also play a role in D3Tx- 
induced AOD. This may be through deprivation ofthymic 
hormones and/or defective thymic-hypothalamic-gonadal 
regulation.  It is conceivable that Aod2 may control suscep- 
tibility  to  the  aforementioned  endocrinologic  defects  ob- 
served  in D3Tx  mice.  Of particular  significance  with  re- 
gard  to  potential  thymus-neuroendocrine  interactions,  it 
has recently been demonstrated that a neuroendocrine sig- 
nal initiated  by the  thymus during fetal  or neonatal  life is 
required for maturation of certain populations ofT cells (37). 
The identification  of genes controlling AOD in mice is 
directly  applicable  to  the  genetic  analysis  of POF  in  hu- 
mans. Aod2 resides in the human syntenic group 4q25-q27, 
that is,  112 is at  4q26-q27  and Fgfb is  at 4q25-q27.  Simi- 
larly,  the human homologue of Aodl  resides  in a syntenic 
group on either chromosome 3 or 22 (38). With this infor- 
mation, we are now in a position to ascertain whether the 
human homologues of these  two genes play a role in the 
etiology of familial  POF.  In addition,  this  approach  is  of 
potential  significance  with  regard  to  differential  diagnosis 
and treatment of the disease. 
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